ADVERTISEMENT RETURN TO ISSUEEditorialNEXTNew Frontiers in Kinases: Second Generation InhibitorsStefan Laufer and Jürgen BajorathCite this: J. Med. Chem. 2014, 57, 6, 2167–2168Publication Date (Web):March 7, 2014Publication History Published online7 March 2014Published inissue 27 March 2014https://pubs.acs.org/doi/10.1021/jm500195xhttps://doi.org/10.1021/jm500195xeditorialACS PublicationsCopyright © 2014 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissions This publication is free to access through this site. Learn MoreArticle Views2951Altmetric-Citations23LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail PDF (124 KB) Get e-AlertscloseSUBJECTS:Cancer,Inhibitors,Kinase inhibitors,Medicinal chemistry,Peptides and proteins Get e-Alerts
No takes yet. Share an insight, caveat, or question.
Laufer et al. (2014) studied this question.